C.QNTM
|
Due to various factors, primarily relating to challenges with patient...
|
C.QNTM
|
The Company is expected to randomize 352 patients with COVID-19 infection to...
|
C.QNTM
|
The Company continues to pursue its strategy of completing a Phase 2 clinical...
|
C.QNTM
|
Let's invest now!
|
C.QNTM
|
Forward-Looking Information includes, but is not limited to, information with...
|
C.QNTM
|
Certain statements contained in this press release constitute "forward...
|
C.QNTM
|
I wish nothing but pure success and growth in this company. May you continue...
|
C.QNTM
|
Neither the Canadian Securities Exchange nor its regulation services provider...
|
C.QNTM
|
Severe COVID-19 is characterized by an over-exuberant inflammatory response...
|
C.QNTM
|
Don't waste time and buy more now! Best decision I've ever made so...
|
C.QNTM
|
The Company filed an IND with the U.S. Food and Drug Administration (“FDA...
|
C.QNTM
|
FSD Pharma BioSciences, Inc., a wholly-owned subsidiary, is a specialty...
|
C.QNTM
|
My investment in this company never stop growing! I'm amazed! I'm...
|
C.QNTM
|
FSD Pharma Inc. is a publicly-traded holding company.
|
C.QNTM
|
We can’t deny the fact of how good and amazing the company is from the team...
|
C.QNTM
|
This press release does not constitute an offer to sell or the solicitation...
|
C.QNTM
|
They also offer job for those who are jobless, where can you find a comapny...
|
C.QNTM
|
The Company expects to use any net proceeds of the Offering to finance future...
|
C.QNTM
|
Alternatively, the Sales Agent will provide copies of the Prospectus...
|
C.QNTM
|
And also one of the best quality that FSD possesses is that they always make...
|